In excess of 400 hundred Grail (ILMN) patients wrongly told they may have cancer, according to FT

Via FT

02 Jun 2023 - 20:24- Equities- Source: FT

Life Sciences Tools & Services (Group)Pharmaceuticals, Biotechnology & Life SciencesIllumina IncLife Sciences Tools & ServicesILMN.USEquitiesILMNS&P 500 IndexNASDAQ 100 IndexAsian Session

Subscribe Now to Newsquawk

Click here for a 1 week free trial

Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include: